Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:21 pm Sale | 13G | Neoleukin Therapeutics, Inc. NLTX | Redmile Group LLC | 3,030,566 6.9% | -1,290,994 (-29.87%) | View |
| 2023-02-03 11:56 am Sale | 13G | Neoleukin Therapeutics, Inc. NLTX | PICTET ASSET MANAGEMENT SA | 0 0% | -2,574,289 (Position Closed) | View |
| 2023-01-19 4:10 pm Sale | 13G | Neoleukin Therapeutics, Inc. NLTX | MILLENNIUM MANAGEMENT LLC | 1,587,267 3.7% | -545,319 (-25.57%) | View |
| 2022-12-30 4:29 pm Purchase | 13G | Neoleukin Therapeutics, Inc. NLTX | Lynx1 Capital Management LP | 2,291,133 5.38% | 2,291,133 (New Position) | View |
| 2022-07-19 4:08 pm Purchase | 13G | Neoleukin Therapeutics, Inc. NLTX | MILLENNIUM MANAGEMENT LLC | 2,132,586 5% | 21,165 (+1.00%) | View |
| 2022-07-15 4:04 pm Sale | 13G | Neoleukin Therapeutics, Inc. NLTX | MILLENNIUM MANAGEMENT LLC | 2,111,421 4.97% | -5,386 (-0.25%) | View |
| 2022-07-08 4:57 pm Sale | 13G | Neoleukin Therapeutics, Inc. NLTX | BlackRock Inc. BLK | 910,832 2.1% | -1,693,813 (-65.03%) | View |
| 2022-07-07 4:56 pm Purchase | 13G | Neoleukin Therapeutics, Inc. NLTX | MILLENNIUM MANAGEMENT LLC | 2,116,807 4.98% | 2,116,807 (New Position) | View |
| 2022-02-14 5:07 pm Purchase | 13G | Neoleukin Therapeutics, Inc. NLTX | Redmile Group LLC | 4,321,560 9.9% | 125,902 (+3.00%) | View |
| 2022-02-14 3:03 pm Sale | 13G | Neoleukin Therapeutics, Inc. NLTX | EcoR1 Capital LLC | 860,619 2% | -2,262,085 (-72.44%) | View |
| 2022-02-11 4:06 pm Sale | 13G | Neoleukin Therapeutics, Inc. NLTX | Silva Manzano Daniel Adriano | 2,909,168 6.8% | -28,978 (-0.99%) | View |
| 2022-02-11 4:06 pm Purchase | 13G | Neoleukin Therapeutics, Inc. NLTX | Ulge Umut | 3,127,733 7.3% | 182,292 (+6.19%) | View |
| 2022-02-10 11:10 am Purchase | 13G | Neoleukin Therapeutics, Inc. NLTX | PICTET ASSET MANAGEMENT SA | 2,574,289 6.07% | 2,574,289 (New Position) | View |
| 2022-02-02 7:18 pm Sale | 13G | Neoleukin Therapeutics, Inc. NLTX | BlackRock Inc. BLK | 2,604,645 6.1% | -80,265 (-2.99%) | View |
| 2021-02-16 4:10 pm Purchase | 13G | Neoleukin Therapeutics, Inc. NLTX | Redmile Group LLC | 4,195,658 9.9% | 4,195,658 (New Position) | View |
| 2021-02-16 12:05 pm Sale | 13G | Neoleukin Therapeutics, Inc. NLTX | EcoR1 Capital LLC | 3,122,704 7.5% | -793,176 (-20.26%) | View |
| 2021-02-12 4:27 pm Sale | 13G | Neoleukin Therapeutics, Inc. NLTX | Ulge Umut | 2,945,441 6.98% | -166,455 (-5.35%) | View |
| 2021-02-12 4:25 pm Sale | 13G | Neoleukin Therapeutics, Inc. NLTX | Silva Manzano Daniel Adriano | 2,938,146 6.96% | -173,750 (-5.58%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | Neoleukin Therapeutics, Inc. NLTX | BlackRock Inc. BLK | 2,684,910 6.4% | 1,670,613 (+164.71%) | View |
| 2020-12-23 5:11 pm Purchase | 13D | Neoleukin Therapeutics, Inc. NLTX | BAKER BROS. ADVISORS LP | 4,229,827 9.99% | 424,827 (+11.16%) | View |